ZWJ Investment Counsel’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,160
Closed -$290K 179
2021
Q4
$290K Hold
2,160
0.01% 155
2021
Q3
$295K Sell
2,160
-720
-25% -$90.8K 0.02% 144
2021
Q2
$307K Hold
2,880
0.02% 145
2021
Q1
$259K Hold
2,880
0.02% 155
2020
Q4
$266K Buy
+2,880
New +$257K 0.02% 149

Other funds holding DXCM

ZWJ Investment Counsel's DXCM Position: Q1 2022 in Review

ZWJ Investment Counsel sold out of DexCom (DXCM) in Q1 2022, closing a stake of 2,160 shares — an estimated $290K sold.

ZWJ Investment Counsel first reported a position in DXCM in Q4 2020 and held it in 5 quarters. The position peaked at $307K in Q2 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • ZWJ Investment Counsel reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • ZWJ Investment Counsel sold 2,160 DexCom shares in Q1 2022, an estimated $290K.
  • ZWJ Investment Counsel first reported a position in DexCom in Q4 2020 and held it in 5 quarters.
  • ZWJ Investment Counsel's DexCom position peaked at $307K in Q2 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on ZWJ Investment Counsel's 13F filing for Q1 2022, filed 10 May 2022.